Please login to the form below

Not currently logged in
Email:
Password:

Bitter pill awards for pharma firms

Health advocacy group highlights 'questionable' prescription drug marketing practices

Five pharma firms in the US have been singled out for 'over-zealous and questionable marketing practices' by health and consumer advocacy group, the Prescription Access Litigation Project (PAL).

PAL gave 'bitter pill' awards to Sepracor for sleeping disorder drug, Lunesta, sanofi-aventis for sleeping pill, Ambien, Eli Lilly for attention deficit hyperactivity disorder drug, Strattera, and AstraZeneca for cholesterol-lowering drug, Crestor.

The awards were created in 2005 to highlight the potential problems of excessive prescription drug marketing, particularly direct-to-consumer advertising, the group said.

ìA lot of money is riding on drug companies convincing consumers that they have insomnia, acid reflux, high cholesterol, allergies, depression, toenail fungus and erectile dysfunction, and that they need to have expensive brand-name drugs to treat them,î said PAL director, Alex Sugarman-Brozan.

PAL also gave an award to US pharmaceutical trade organisation, the Pharmaceutical Research and Manufacturers of America (PhRMA), for not enforcing the direct-to-consumer advertising guidelines it issued last year.

In a statement, PhRMA responded that the guidelines ìare beginning to work, and we believe they should be given additional time to function more robustlyî.

2nd September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...